A growing body of research suggests Shingrix can reduce the risk of heart disease and delay dementia.

GSK’s (GSK) shingles vaccine Shingrix is associated with a lower risk of major cardiovascular events such as stroke compared with Zostavax, a rival shot marketed by Merck (MRK), according to a new ...

Reviewed: ad hoc news New Release & Launch desk. Edited and checked on 2026-06-23, 04:27. Details in the imprint. Shingrix from GSK plc sits in the fridge of a family doctor's practice, the milky ...

LONDON, March 25 (Reuters) - GSK (GSK.L), opens new tab said on Tuesday that it is studying a group of more than a million older adults in the UK to examine whether its best-selling shingles vaccine ...

Researchers investigated whether the shingles (herpes zoster) vaccine can help prevent dementia. Previous studies suggest that certain herpes viruses may contribute to dementia, and vaccines might ...

Dynavax Technologies Corporation (NASDAQ:DVAX) announced topline results from Part 1 of its randomized, observer-blinded, and active-controlled Phase 1/2 clinical trial of Z-1018, a shingles vaccine ...

The U.S. Food and Drug Administration has approved GSK's prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted) for the prevention of shingles (herpes zoster). The ...

GSK (NYSE:GSK) announced Thursday that the U.S. Food and Drug Administration (FDA) approved a new prefilled syringe presentation of its shingles vaccine, Shingrix, offering a convenient administration ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...